Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
Dr Tara Graff, Mission Cancer and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.